Label: VARDENAFIL tablet, orally disintegrating

Overall, the market for vardenafil hydrochloride continues to evolve with rising demand for ED treatments and increased generic availability.

Are erectile dysfunction medicines safe?

The maximum dose should not exceed 10 mg. Severe hepatic dysfunction (Child-Pugh C): Use should be avoided. Comment: The orally disintegrating tablets should not be used in patients with moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic dysfunction. If taking potent or moderate inhibitors of CYP450 3A4, the dose should be adjusted as follows: Ritonavir: No more than 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: No more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: No more than 5 mg in a 24-hour period Safety and efficacy have not been established in patients younger than 18 years. This drug is not indicated for use in pediatric patients.

How is vardenafil supplied (dosage forms)?

This drug can be taken with or without food. The 10 mg orally disintegrating tablet (ODT) provides higher systemic exposure and is not interchangeable with the 10 mg film-coated tablets. The ODT tablet should be taken without liquid and immediately upon removal from the blister. Patients who require a lower or higher dose than 10 mg should be prescribed the film-coated tablets. Patients treated with alpha-blockers, who have previously used vardenafil film-coated tablets, may be switched to ODT tablets at the advice of their healthcare provider.

Patient resources

Patients should stop use of PDE5 inhibitors, including this drug, and seek medical attention in the event of sudden loss of vision in one or both eyes, and decrease or loss of hearing. Symptoms related to postural hypotension may occur, appropriate countermeasures are recommended. Contact the prescribing physician if other antihypertensive drugs or new medications that may interact with this drug are prescribed by another healthcare provider. Patients should contact their healthcare provider for dose modification if they are not satisfied with the quality of their sexual performance with this drug, or in the case of an unwanted side effect. Vardenafil hydrochloride is a phosphodiesterase type 5 (PDE5) inhibitor approved primarily for erectile dysfunction (ED). How does vardenafil compare to other PDE5 inhibitors? Vardenafil has a similar efficacy profile to sildenafil and tadalafil but features a quicker onset of action. Its half-life of 4–5 hours suits flexible dosing.

• Vardenafil 10 mg should not be used with certain medications.
• Grapefruit or grapefruit juice may have interactions.
• Inform your doctor about all health conditions before use.
• The medication may cause vision changes or sensitivity.
• Do not use vardenafil if you have liver or kidney issues.
• The pill helps achieve and maintain an erection.
• Follow prescribed dosage to avoid complications.
• Not effective as an aphrodisiac without sexual stimulation.
• Avoid using recreational drugs along with vardenafil.
• Regular medical check-ups are recommended during use.

Pricing is affected by patent status, regional regulation, competition, and whether the drug is branded or generic. Which markets offer the highest growth potential?

Product	Dosage	Quantity + Bonus	Price
Kamagra Soft Tabs	100 mg	32 Pills	120.11€ 114.39€	Buy
Kamagra Soft Tabs	100 mg	120 + 6 Pills	311.78€ 296.93€	Buy
Levitra Generic	20mg	10 Pills	31.49€ 29.99€	Buy
Levitra Professional	20mg	120 + 4 Pills	348.44€ 331.85€	Buy
Cialis Generic	40mg	20 Pills	59.47€ 56.64€	Buy
Levitra Generic	20mg	30 + 4 Pills	70.59€ 67.23€	Buy
Viagra Generic	50mg	120 + 6 Pills	129.64€ 123.47€	Buy
Cialis Professional	20mg	60 + 2 Pills	183.83€ 175.08€	Buy
Cialis Professional	40mg	90 + 2 Pills	348.59€ 331.99€	Buy
Apcalis SX Oral Jelly	20mg	70 + 7 Sachets	184.98€ 176.17€	Buy
Cialis Black	80mg	10 Pills	43.27€ 41.21€	Buy

Emerging markets such as India, China, and Latin America present the highest growth potential due to increasing prevalence and affordability factors. Are there ongoing research efforts for new formulations? Limited, primarily from generic manufacturers focusing on fast-dissolving forms or combination therapies; innovation is more incremental than breakthrough. Country-specific approval processes, patent laws, and price regulations influence how quickly new generic or branded formulations enter markets. Erectile Dysfunction Drugs Market by Product, Distribution Channel, and Region: Global Forecast to 2028.

See also:

Innovation in delivery mechanisms (e.g., fast-dissolving tabs, new formulations) is limited but ongoing, primarily driven by generic manufacturers. Patent litigation or patent extensions delaying premature ejaculation pills generic entry. Competition from new drugs or alternative therapies. Regulatory changes increasing approval or manufacturing costs. Pricing pressures due to government-mandated price reductions. [5] U.S. Food and Drug Administration (FDA).

• The onset of vardenafil 10 mg is typically 30-60 minutes.
• It can last up to 4-5 hours in some users.
• Vardenafil is contraindicated with certain heart medications.
• Use caution if you have a history of hypotension.
• The tablet may cause mild gastrointestinal upset.
• Do not consume large amounts of alcohol when taking vardenafil.
• Inform your doctor if you experience sudden hearing loss.
• Use only as directed by your healthcare provider.
• Discontinue if you experience persistent erection issues.
• The medication does not increase sexual desire.

10 mg as needed, 60 minutes prior to sexual activity Increase to 20 mg or decrease to 5 mg based on efficacy/tolerability For patients taking potent or moderate inhibitors of CYP3A4, dose adjustment is as follows: Ritonavir: no more than 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: no more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: no more than 5 mg in a 24-hour period.

Adverse Effects

Market growth is driven by increased focus on sexual health, over-the-counter availability in some regions, and newer formulations improving patient adherence. The popularity of combination therapies and the rise of telemedicine further influence demand dynamics. Projection estimates forecast the ED market reaching over $6.5 billion globally by 2028, with vardenafil contributing approximately 15–20% of this value. Compound annual growth rate (CAGR) calculations suggest a 5–6% growth from 2023 to 2028, primarily propelled by: Expansion into emerging markets (Asia-Pacific, Latin America) Increased acceptance of generics, reducing patient costs Rise in over-the-counter product availability Technological innovations in formulation (e.g., fast-dissolving tablets) Regional variations could influence market share: North America is expected to be the dominant segment, but Asia-Pacific will witness the fastest growth, with a CAGR near 8%, due to higher prevalence and lower treatment access costs. Manufacturing costs for vardenafil have declined due to economies of scale and global production.

What is vardenafil, and what is it used for?

Generic production costs are estimated at $0.10–$0.15 per pill, compared to branded formulations at $1.00–$2.00, creating profit margins of 85–90% for generics. Regulatory harmonization reduces approval timelines and cost, fostering quicker market entry. Countries with streamlined approval processes, such as India and Brasil, enable faster revenue realization. Conversely, stringent regulations in the US and EU can delay launches, impacting short-term revenue but fostering long-term stability. Pricing policies vary, with government-mandated price caps in several markets influencing profit margins.

What should I do if I miss a dose of vardenafil?

For instance, India enforces prices 30–40% lower than international reference prices, reducing profit potential but increasing volume sales. Generic vardenafil dominates due to patent expiry, with leading players capturing over 60% of the accessible market: Teva Pharmaceuticals: Largest global producer with extensive distribution channels. Sun Pharma: Focused on Asian markets, rapidly expanding in Latin America. Mylan: Active in the US and Europe with competitive pricing. Brand dominance persists in some regions, especially where patent protections remain valid or where consumer preference favors branded formulations. Cardiovascular effects - patients should not use Vardenafil if sex is inadvisable due to cardiovascular status.

Patient Type	Recommended Dose	Notes
Adult Men with ED	10 mg	1 hour before activity
Elderly Patients	5-10 mg	Adjust based on tolerability
Patients with Liver Impairment	5 mg	Lower dose recommended
Use with CYP3A4 inhibitors	5 mg	To reduce adverse risk

Risk of priapism - in the event that an erection lasts more than 4 hours, the patient should seek immediate medical assistance Effects on the eye - patients should stop treatment and seek medical attention in the event of sudden loss of vision in one or both eyes, which could be sign of nonarteritic anterior ischemic optic neuropathy (NAION).

• Vardenafil 10 mg tablets treat erectile dysfunction in men.
• The medication works by increasing blood flow to the penis.
• Take vardenafil 10 mg about 30 minutes before activity.
• It can be taken with or without food, but high-fat meals may delay effects.
• Maximum recommended dose is one tablet per 24 hours.
• Vardenafil may cause side effects like headache or flushing.
• Do not use vardenafil if you take nitrates for chest pain.
• Consult a doctor before using vardenafil if you have heart problems.
• Store vardenafil tablets at room temperature, away from moisture.
• Alcohol can increase side effects of vardenafil.

Use with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION.

8.7 Renal Impairment

Operational risk stems from supply chain disruptions and geopolitical issues impacting manufacturing or distribution. Patent expirations significantly increased generic entry, reducing prices and expanding access. Revenue growth predictions remain positive but are moderated by regulatory policies and pricing pressures. Emerging markets will drive growth, with regional variations influencing market share. Innovation in formulation remains limited but could alter competitive dynamics. Patients with a "crowed" optic disc may also be at an increased risk of NAION. Sudden hearing loss - patients should stop treatment and seek medical attention in the event of sudden decrease or loss in hearing Alpha-blockers - caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. In some patients, concomitant use of these two drug classes can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting) QT prolongation - patients with congenital QT syndrome or taking class IA or III antiarrhythmics should avoid using Vardenafil Other erectile dysfunction therapies - the safety and efficacy of vardenafil used in combination with other treatments for ED have not been studied.

Brand Name	Manufacturer	Formulation Type	Price Range	Notes
Levitra	Bayer	Tablet	Moderate	Widely used
Staxyn	Bayer	Orally disintegrating tablet	Similar price	Alternative formulation
Generic Vendors	Multiple	Tablet	Lower	Cost-effective option

Signs and symptoms may include reversible back pain/myalgia and/or "abnormal vision." Standard supportive measures should be taken as required. Renal dialysis is not expected to accelerate clearance as vardenafil is highly bound to plasma proteins and not significantly eliminated in the urine.

What It Contains

It is marketed under brand names such as Levitra and Staxyn. Globally, the ED treatment market has valued approximately $4 billion in 2022. The segment including vardenafil accounts for roughly 20% of this market, with an estimated revenue of $800 million in 2022. Key manufacturers include Bayer, Teva Pharmaceuticals, and Sun Pharma. The generic segment's sexual tablets for women share increased from 15% in 2015 to over 50% by 2022, driven by patent expirations and regional generics proliferation.

Incidence not known

Bayer's patent for Levitra expired in 2018, allowing generic manufacturers to enter multiple markets. This reduced prices by an estimated 40–60%, impacting branded sales. The expiration facilitated increased accessibility and expanded the patient base, especially in emerging markets. In the US, the final patent expiration occurred in 2020. The European patent expired in 2017, leading to a surge in generic imports.

How should I store vardenafil?

Patent cliffs across major markets significantly shifted revenue streams, transitioning from branded dominance to a generics-focused market. The drug's pharmacology remains stable with a half-life of 4–5 hours, allowing for flexible dosing. It competes with tadalafil (Cialis) and sildenafil (Viagra), which have similar efficacy but differ in duration and side effect profile. Commercially, the ED market is expanding due to increasing prevalence related to aging populations and rising awareness. The global aging demographic is expected to increase ED prevalence from 10% to 30% in men aged 40–70.